The global Platinum-based Anticancer APIs market size was valued at USD million in 2023 and is forecast to a readjusted size of USD million by 2030 with a CAGR of % during review period.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Thereport includes an overview of the development of the Platinum-based Anticancer APIs industry chain, the market status of Testicular Cancer (Cisplatin, Carboplatin), Osteosarcoma (Cisplatin, Carboplatin), and key enterprises in developed and developing market, and analysed the cutting-edge technology, patent, hot applications and market trends of Platinum-based Anticancer APIs.
Regionally, the report analyzes the Platinum-based Anticancer APIs markets in key regions. North America and Europe are experiencing steady growth, driven by government initiatives and increasing consumer awareness. Asia-Pacific, particularly China, leads the global Platinum-based Anticancer APIs market, with robust domestic demand, supportive policies, and a strong manufacturing base.
Key Features:
The report presents comprehensive understanding of the Platinum-based Anticancer APIs market. It provides a holistic view of the industry, as well as detailed insights into individual components and stakeholders. The report analysis market dynamics, trends, challenges, and opportunities within the Platinum-based Anticancer APIs industry.
The report involves analyzing the market at a macro level:
Market Sizing and Segmentation: Report collect data on the overall market size, including the sales quantity (Kiloton), revenue generated, and market share of different by Type (e.g., Cisplatin, Carboplatin).
Industry Analysis: Report analyse the broader industry trends, such as government policies and regulations, technological advancements, consumer preferences, and market dynamics. This analysis helps in understanding the key drivers and challenges influencing the Platinum-based Anticancer APIs market.
Regional Analysis: The report involves examining the Platinum-based Anticancer APIs market at a regional or national level. Report analyses regional factors such as government incentives, infrastructure development, economic conditions, and consumer behaviour to identify variations and opportunities within different markets.
Market Projections: Report covers the gathered data and analysis to make future projections and forecasts for the Platinum-based Anticancer APIs market. This may include estimating market growth rates, predicting market demand, and identifying emerging trends.
The report also involves a more granular approach to Platinum-based Anticancer APIs:
Company Analysis: Report covers individual Platinum-based Anticancer APIs manufacturers, suppliers, and other relevant industry players. This analysis includes studying their financial performance, market positioning, product portfolios, partnerships, and strategies.
Consumer Analysis: Report covers data on consumer behaviour, preferences, and attitudes towards Platinum-based Anticancer APIs This may involve surveys, interviews, and analysis of consumer reviews and feedback from different by Application (Testicular Cancer, Osteosarcoma).
Technology Analysis: Report covers specific technologies relevant to Platinum-based Anticancer APIs. It assesses the current state, advancements, and potential future developments in Platinum-based Anticancer APIs areas.
Competitive Landscape: By analyzing individual companies, suppliers, and consumers, the report present insights into the competitive landscape of the Platinum-based Anticancer APIs market. This analysis helps understand market share, competitive advantages, and potential areas for differentiation among industry players.
Market Validation: The report involves validating findings and projections through primary research, such as surveys, interviews, and focus groups.
Market Segmentation
Platinum-based Anticancer APIs market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value.
Market segment by Type
Cisplatin
Carboplatin
Oxaliplatin
Nedaplatin
Others
Market segment by Application
Testicular Cancer
Osteosarcoma
Breast Cancer
Esophageal Cancer
NSCLC
Other
Major players covered
Jiangsu Hengrui Medicine
Nanjing Pharmaceutical Factory
Qilu Pharmaceutical
Neptunus
Hisun
Jiangsu HaiCi biological pharmaceutical
Kunming Guiyan Pharmaceutical
Lingnan Pharmacy
Jinzhou Jiutai Pharmaceutical
Nanjing Hairun Pharmaceutical
Simcere
Teva
Cipla
Heraeus
Hospira(Pfizer)
Taj Pharmaceuticals
Umicore Precious Metals Chemistry
Market segment by region, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Platinum-based Anticancer APIs product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Platinum-based Anticancer APIs, with price, sales, revenue and global market share of Platinum-based Anticancer APIs from 2019 to 2024.
Chapter 3, the Platinum-based Anticancer APIs competitive situation, sales quantity, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Platinum-based Anticancer APIs breakdown data are shown at the regional level, to show the sales quantity, consumption value and growth by regions, from 2019 to 2030.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2019 to 2030.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value and market share for key countries in the world, from 2017 to 2023.and Platinum-based Anticancer APIs market forecast, by regions, type and application, with sales and revenue, from 2025 to 2030.
Chapter 12, market dynamics, drivers, restraints, trends and Porters Five Forces analysis.
Chapter 13, the key raw materials and key suppliers, and industry chain of Platinum-based Anticancer APIs.
Chapter 14 and 15, to describe Platinum-based Anticancer APIs sales channel, distributors, customers, research findings and conclusion.
Please Note - This is an on demand report and will be delivered in 2 business days (48 Hours) post payment.
1 Market Overview
1.1 Product Overview and Scope of Platinum-based Anticancer APIs
1.2 Market Estimation Caveats and Base Year
1.3 Market Analysis by Type
1.3.1 Overview: Global Platinum-based Anticancer APIs Consumption Value by Type: 2019 Versus 2023 Versus 2030
1.3.2 Cisplatin
1.3.3 Carboplatin
1.3.4 Oxaliplatin
1.3.5 Nedaplatin
1.3.6 Others
1.4 Market Analysis by Application
1.4.1 Overview: Global Platinum-based Anticancer APIs Consumption Value by Application: 2019 Versus 2023 Versus 2030
1.4.2 Testicular Cancer
1.4.3 Osteosarcoma
1.4.4 Breast Cancer
1.4.5 Esophageal Cancer
1.4.6 NSCLC
1.4.7 Other
1.5 Global Platinum-based Anticancer APIs Market Size & Forecast
1.5.1 Global Platinum-based Anticancer APIs Consumption Value (2019 & 2023 & 2030)
1.5.2 Global Platinum-based Anticancer APIs Sales Quantity (2019-2030)
1.5.3 Global Platinum-based Anticancer APIs Average Price (2019-2030)
2 Manufacturers Profiles
2.1 Jiangsu Hengrui Medicine
2.1.1 Jiangsu Hengrui Medicine Details
2.1.2 Jiangsu Hengrui Medicine Major Business
2.1.3 Jiangsu Hengrui Medicine Platinum-based Anticancer APIs Product and Services
2.1.4 Jiangsu Hengrui Medicine Platinum-based Anticancer APIs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.1.5 Jiangsu Hengrui Medicine Recent Developments/Updates
2.2 Nanjing Pharmaceutical Factory
2.2.1 Nanjing Pharmaceutical Factory Details
2.2.2 Nanjing Pharmaceutical Factory Major Business
2.2.3 Nanjing Pharmaceutical Factory Platinum-based Anticancer APIs Product and Services
2.2.4 Nanjing Pharmaceutical Factory Platinum-based Anticancer APIs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.2.5 Nanjing Pharmaceutical Factory Recent Developments/Updates
2.3 Qilu Pharmaceutical
2.3.1 Qilu Pharmaceutical Details
2.3.2 Qilu Pharmaceutical Major Business
2.3.3 Qilu Pharmaceutical Platinum-based Anticancer APIs Product and Services
2.3.4 Qilu Pharmaceutical Platinum-based Anticancer APIs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.3.5 Qilu Pharmaceutical Recent Developments/Updates
2.4 Neptunus
2.4.1 Neptunus Details
2.4.2 Neptunus Major Business
2.4.3 Neptunus Platinum-based Anticancer APIs Product and Services
2.4.4 Neptunus Platinum-based Anticancer APIs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.4.5 Neptunus Recent Developments/Updates
2.5 Hisun
2.5.1 Hisun Details
2.5.2 Hisun Major Business
2.5.3 Hisun Platinum-based Anticancer APIs Product and Services
2.5.4 Hisun Platinum-based Anticancer APIs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.5.5 Hisun Recent Developments/Updates
2.6 Jiangsu HaiCi biological pharmaceutical
2.6.1 Jiangsu HaiCi biological pharmaceutical Details
2.6.2 Jiangsu HaiCi biological pharmaceutical Major Business
2.6.3 Jiangsu HaiCi biological pharmaceutical Platinum-based Anticancer APIs Product and Services
2.6.4 Jiangsu HaiCi biological pharmaceutical Platinum-based Anticancer APIs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.6.5 Jiangsu HaiCi biological pharmaceutical Recent Developments/Updates
2.7 Kunming Guiyan Pharmaceutical
2.7.1 Kunming Guiyan Pharmaceutical Details
2.7.2 Kunming Guiyan Pharmaceutical Major Business
2.7.3 Kunming Guiyan Pharmaceutical Platinum-based Anticancer APIs Product and Services
2.7.4 Kunming Guiyan Pharmaceutical Platinum-based Anticancer APIs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.7.5 Kunming Guiyan Pharmaceutical Recent Developments/Updates
2.8 Lingnan Pharmacy
2.8.1 Lingnan Pharmacy Details
2.8.2 Lingnan Pharmacy Major Business
2.8.3 Lingnan Pharmacy Platinum-based Anticancer APIs Product and Services
2.8.4 Lingnan Pharmacy Platinum-based Anticancer APIs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.8.5 Lingnan Pharmacy Recent Developments/Updates
2.9 Jinzhou Jiutai Pharmaceutical
2.9.1 Jinzhou Jiutai Pharmaceutical Details
2.9.2 Jinzhou Jiutai Pharmaceutical Major Business
2.9.3 Jinzhou Jiutai Pharmaceutical Platinum-based Anticancer APIs Product and Services
2.9.4 Jinzhou Jiutai Pharmaceutical Platinum-based Anticancer APIs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.9.5 Jinzhou Jiutai Pharmaceutical Recent Developments/Updates
2.10 Nanjing Hairun Pharmaceutical
2.10.1 Nanjing Hairun Pharmaceutical Details
2.10.2 Nanjing Hairun Pharmaceutical Major Business
2.10.3 Nanjing Hairun Pharmaceutical Platinum-based Anticancer APIs Product and Services
2.10.4 Nanjing Hairun Pharmaceutical Platinum-based Anticancer APIs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.10.5 Nanjing Hairun Pharmaceutical Recent Developments/Updates
2.11 Simcere
2.11.1 Simcere Details
2.11.2 Simcere Major Business
2.11.3 Simcere Platinum-based Anticancer APIs Product and Services
2.11.4 Simcere Platinum-based Anticancer APIs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.11.5 Simcere Recent Developments/Updates
2.12 Teva
2.12.1 Teva Details
2.12.2 Teva Major Business
2.12.3 Teva Platinum-based Anticancer APIs Product and Services
2.12.4 Teva Platinum-based Anticancer APIs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.12.5 Teva Recent Developments/Updates
2.13 Cipla
2.13.1 Cipla Details
2.13.2 Cipla Major Business
2.13.3 Cipla Platinum-based Anticancer APIs Product and Services
2.13.4 Cipla Platinum-based Anticancer APIs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.13.5 Cipla Recent Developments/Updates
2.14 Heraeus
2.14.1 Heraeus Details
2.14.2 Heraeus Major Business
2.14.3 Heraeus Platinum-based Anticancer APIs Product and Services
2.14.4 Heraeus Platinum-based Anticancer APIs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.14.5 Heraeus Recent Developments/Updates
2.15 Hospira(Pfizer)
2.15.1 Hospira(Pfizer) Details
2.15.2 Hospira(Pfizer) Major Business
2.15.3 Hospira(Pfizer) Platinum-based Anticancer APIs Product and Services
2.15.4 Hospira(Pfizer) Platinum-based Anticancer APIs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.15.5 Hospira(Pfizer) Recent Developments/Updates
2.16 Taj Pharmaceuticals
2.16.1 Taj Pharmaceuticals Details
2.16.2 Taj Pharmaceuticals Major Business
2.16.3 Taj Pharmaceuticals Platinum-based Anticancer APIs Product and Services
2.16.4 Taj Pharmaceuticals Platinum-based Anticancer APIs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.16.5 Taj Pharmaceuticals Recent Developments/Updates
2.17 Umicore Precious Metals Chemistry
2.17.1 Umicore Precious Metals Chemistry Details
2.17.2 Umicore Precious Metals Chemistry Major Business
2.17.3 Umicore Precious Metals Chemistry Platinum-based Anticancer APIs Product and Services
2.17.4 Umicore Precious Metals Chemistry Platinum-based Anticancer APIs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.17.5 Umicore Precious Metals Chemistry Recent Developments/Updates
3 Competitive Environment: Platinum-based Anticancer APIs by Manufacturer
3.1 Global Platinum-based Anticancer APIs Sales Quantity by Manufacturer (2019-2024)
3.2 Global Platinum-based Anticancer APIs Revenue by Manufacturer (2019-2024)
3.3 Global Platinum-based Anticancer APIs Average Price by Manufacturer (2019-2024)
3.4 Market Share Analysis (2023)
3.4.1 Producer Shipments of Platinum-based Anticancer APIs by Manufacturer Revenue ($MM) and Market Share (%): 2023
3.4.2 Top 3 Platinum-based Anticancer APIs Manufacturer Market Share in 2023
3.4.2 Top 6 Platinum-based Anticancer APIs Manufacturer Market Share in 2023
3.5 Platinum-based Anticancer APIs Market: Overall Company Footprint Analysis
3.5.1 Platinum-based Anticancer APIs Market: Region Footprint
3.5.2 Platinum-based Anticancer APIs Market: Company Product Type Footprint
3.5.3 Platinum-based Anticancer APIs Market: Company Product Application Footprint
3.6 New Market Entrants and Barriers to Market Entry
3.7 Mergers, Acquisition, Agreements, and Collaborations
4 Consumption Analysis by Region
4.1 Global Platinum-based Anticancer APIs Market Size by Region
4.1.1 Global Platinum-based Anticancer APIs Sales Quantity by Region (2019-2030)
4.1.2 Global Platinum-based Anticancer APIs Consumption Value by Region (2019-2030)
4.1.3 Global Platinum-based Anticancer APIs Average Price by Region (2019-2030)
4.2 North America Platinum-based Anticancer APIs Consumption Value (2019-2030)
4.3 Europe Platinum-based Anticancer APIs Consumption Value (2019-2030)
4.4 Asia-Pacific Platinum-based Anticancer APIs Consumption Value (2019-2030)
4.5 South America Platinum-based Anticancer APIs Consumption Value (2019-2030)
4.6 Middle East and Africa Platinum-based Anticancer APIs Consumption Value (2019-2030)
5 Market Segment by Type
5.1 Global Platinum-based Anticancer APIs Sales Quantity by Type (2019-2030)
5.2 Global Platinum-based Anticancer APIs Consumption Value by Type (2019-2030)
5.3 Global Platinum-based Anticancer APIs Average Price by Type (2019-2030)
6 Market Segment by Application
6.1 Global Platinum-based Anticancer APIs Sales Quantity by Application (2019-2030)
6.2 Global Platinum-based Anticancer APIs Consumption Value by Application (2019-2030)
6.3 Global Platinum-based Anticancer APIs Average Price by Application (2019-2030)
7 North America
7.1 North America Platinum-based Anticancer APIs Sales Quantity by Type (2019-2030)
7.2 North America Platinum-based Anticancer APIs Sales Quantity by Application (2019-2030)
7.3 North America Platinum-based Anticancer APIs Market Size by Country
7.3.1 North America Platinum-based Anticancer APIs Sales Quantity by Country (2019-2030)
7.3.2 North America Platinum-based Anticancer APIs Consumption Value by Country (2019-2030)
7.3.3 United States Market Size and Forecast (2019-2030)
7.3.4 Canada Market Size and Forecast (2019-2030)
7.3.5 Mexico Market Size and Forecast (2019-2030)
8 Europe
8.1 Europe Platinum-based Anticancer APIs Sales Quantity by Type (2019-2030)
8.2 Europe Platinum-based Anticancer APIs Sales Quantity by Application (2019-2030)
8.3 Europe Platinum-based Anticancer APIs Market Size by Country
8.3.1 Europe Platinum-based Anticancer APIs Sales Quantity by Country (2019-2030)
8.3.2 Europe Platinum-based Anticancer APIs Consumption Value by Country (2019-2030)
8.3.3 Germany Market Size and Forecast (2019-2030)
8.3.4 France Market Size and Forecast (2019-2030)
8.3.5 United Kingdom Market Size and Forecast (2019-2030)
8.3.6 Russia Market Size and Forecast (2019-2030)
8.3.7 Italy Market Size and Forecast (2019-2030)
9 Asia-Pacific
9.1 Asia-Pacific Platinum-based Anticancer APIs Sales Quantity by Type (2019-2030)
9.2 Asia-Pacific Platinum-based Anticancer APIs Sales Quantity by Application (2019-2030)
9.3 Asia-Pacific Platinum-based Anticancer APIs Market Size by Region
9.3.1 Asia-Pacific Platinum-based Anticancer APIs Sales Quantity by Region (2019-2030)
9.3.2 Asia-Pacific Platinum-based Anticancer APIs Consumption Value by Region (2019-2030)
9.3.3 China Market Size and Forecast (2019-2030)
9.3.4 Japan Market Size and Forecast (2019-2030)
9.3.5 Korea Market Size and Forecast (2019-2030)
9.3.6 India Market Size and Forecast (2019-2030)
9.3.7 Southeast Asia Market Size and Forecast (2019-2030)
9.3.8 Australia Market Size and Forecast (2019-2030)
10 South America
10.1 South America Platinum-based Anticancer APIs Sales Quantity by Type (2019-2030)
10.2 South America Platinum-based Anticancer APIs Sales Quantity by Application (2019-2030)
10.3 South America Platinum-based Anticancer APIs Market Size by Country
10.3.1 South America Platinum-based Anticancer APIs Sales Quantity by Country (2019-2030)
10.3.2 South America Platinum-based Anticancer APIs Consumption Value by Country (2019-2030)
10.3.3 Brazil Market Size and Forecast (2019-2030)
10.3.4 Argentina Market Size and Forecast (2019-2030)
11 Middle East & Africa
11.1 Middle East & Africa Platinum-based Anticancer APIs Sales Quantity by Type (2019-2030)
11.2 Middle East & Africa Platinum-based Anticancer APIs Sales Quantity by Application (2019-2030)
11.3 Middle East & Africa Platinum-based Anticancer APIs Market Size by Country
11.3.1 Middle East & Africa Platinum-based Anticancer APIs Sales Quantity by Country (2019-2030)
11.3.2 Middle East & Africa Platinum-based Anticancer APIs Consumption Value by Country (2019-2030)
11.3.3 Turkey Market Size and Forecast (2019-2030)
11.3.4 Egypt Market Size and Forecast (2019-2030)
11.3.5 Saudi Arabia Market Size and Forecast (2019-2030)
11.3.6 South Africa Market Size and Forecast (2019-2030)
12 Market Dynamics
12.1 Platinum-based Anticancer APIs Market Drivers
12.2 Platinum-based Anticancer APIs Market Restraints
12.3 Platinum-based Anticancer APIs Trends Analysis
12.4 Porters Five Forces Analysis
12.4.1 Threat of New Entrants
12.4.2 Bargaining Power of Suppliers
12.4.3 Bargaining Power of Buyers
12.4.4 Threat of Substitutes
12.4.5 Competitive Rivalry
13 Raw Material and Industry Chain
13.1 Raw Material of Platinum-based Anticancer APIs and Key Manufacturers
13.2 Manufacturing Costs Percentage of Platinum-based Anticancer APIs
13.3 Platinum-based Anticancer APIs Production Process
13.4 Platinum-based Anticancer APIs Industrial Chain
14 Shipments by Distribution Channel
14.1 Sales Channel
14.1.1 Direct to End-User
14.1.2 Distributors
14.2 Platinum-based Anticancer APIs Typical Distributors
14.3 Platinum-based Anticancer APIs Typical Customers
15 Research Findings and Conclusion
16 Appendix
16.1 Methodology
16.2 Research Process and Data Source
16.3 Disclaimer
Jiangsu Hengrui Medicine
Nanjing Pharmaceutical Factory
Qilu Pharmaceutical
Neptunus
Hisun
Jiangsu HaiCi biological pharmaceutical
Kunming Guiyan Pharmaceutical
Lingnan Pharmacy
Jinzhou Jiutai Pharmaceutical
Nanjing Hairun Pharmaceutical
Simcere
Teva
Cipla
Heraeus
Hospira(Pfizer)
Taj Pharmaceuticals
Umicore Precious Metals Chemistry
听
听
*If Applicable.
